Shares of Rocket Lab (NASDAQ: RKLB) soared 155% in November, according to data from S&P Global Market Intelligence. The space flight and rocket company keeps announcing new missions and posted a promising earnings result in the month.

Rocket Lab stock is surging but faces near-term weakness. Strong revenue growth, but overvalued. Click here for a technical analysis.

The recent market rotation toward smaller companies has lifted many boats, but Rocket Lab USA's (NASDAQ: RKLB) performance stands out even in this environment. The space company's shares have rocketed 320% higher this year at the time of this writing,

Some Rocket Lab insiders are cashing in on the stock's incredible run. On Nov. 27, Rocket Lab submitted a series of filings to the SEC detailing stock sales by four company inside

Rocket Lab's financial performance is on the rise with a $1.05 billion backlog, $105M revenue in Q3 2024, and plans for profitability in 2025. Read why RKLB is a Buy.

If you own Rocket Lab stock, you can thank the friendly analysts at Roth MKM for that, because Roth raised its price target on buy-rated Rocket Lab this morning. Roth MKM predicts Rocket Lab shares -- which cost just a bit over $23 a share right now -- will rise a further 29% to hit $30 a share within a year.